Edwards Lifesciences (EW) Tops Q1 EPS by 10c; Raises Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
Edwards Lifesciences Reports First Quarter Results
April 23, 2019 4:15 PM EDTIRVINE, Calif., April 23, 2019 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, today reported financial results for the quarter ended March 31, 2019.
First Quarter and Recent Highlights
Sales grew 11% to $993 million;... More